Use of pharmacoeconomics in prescribing research. Part 1: costs - moving beyond the acquisition price for drugs

Author:

Robertson J.,Lang D.,Hill S.

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference24 articles.

1. Problems with the interpretation of pharmacoeconomic analyses. A review of submissions to the Australian Pharmaceutical Benefits Scheme;Hill;JAMA,2000

2. Opportunity costs;Palmer;BMJ,1999

3. Introduction to health economics for physicians;Meltzer;Lancet,2001

4. Department of Health and Aged Care 2002 Guidelines for the pharmaceutical industry on preparation of submissions to the Pharmaceutical Benefits Advisory Committee: including major submissions involving economic analyses. http://www.health. gov.au/pbs/pubs/pharmpac/gusubpac.htm

Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Drugs for rare disorders;British Journal of Clinical Pharmacology;2017-06-27

2. Policy options for pharmaceutical pricing and purchasing: issues for low- and middle-income countries;Health Policy and Planning;2014-01-13

3. 1. Issues on Estimating Costs in Economic Evaluation;Japanese Journal of Pharmacoepidemiology/Yakuzai ekigaku;2012

4. Sobre la necesidad de la farmacoeconomía. Comenzar por los principios;Revista Colombiana de Reumatología;2011-09

5. Pharmacoeconomy: an indispensable tool for the rationalization of health costs;Brazilian Journal of Pharmaceutical Sciences;2011-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3